COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2020

Jul 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2020-07-10

Reporting Person: Dreyer Scott (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-10	Common Stock	F	594	$16.73	Disposed	47847	Direct
2020-07-13	Common Stock	S	1429	$17.01	Disposed	46418	Direct

Footnotes

F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019.